ClinicalTrials.gov record
Completed Phase 3 Interventional

Reformulated PG324 Ophthalmic Solution for Intraocular Pressure Reduction

ClinicalTrials.gov ID: NCT07082816

Public ClinicalTrials.gov record NCT07082816. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 18, 2026, 4:13 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, Prospective, Double-Masked, Randomized, Multi-Center, Active-Controlled, Parallel Group Comparison Study Assessing the Ocular Hypotensive Efficacy of Reformulated PG324 Ophthalmic Solution in Subjects With Elevated Intraocular Pressure

Study identification

NCT ID
NCT07082816
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Alcon Research
Industry
Enrollment
489 participants

Conditions and interventions

Interventions

  • Netarsudil 0.01%/latanoprost 0.005% ophthalmic solution Drug
  • Netarsudil 0.02%/latanoprost 0.005% ophthalmic solution Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 1, 2025
Primary completion
Apr 5, 2026
Completion
Apr 5, 2026
Last update posted
Apr 20, 2026

2025 – 2026

United States locations

U.S. sites
30
U.S. states
16
U.S. cities
28
Facility City State ZIP Site status
Trinity Research Group Dothan Alabama 36301
Eye Doctors of Arizona Phoenix Arizona 85028
Orange County Ophthalmology Medical Group Garden Grove California 92843
United Medical Research Institute Inglewood California 90301
Eye Research Foundation Newport Beach California 92663
North Bay Eye Associates Petaluma California 94954
Sacramento Eye Consultants Sacramento California 95815
Central Florida Eye Specialists DeLand Florida 32720
Glaucoma Specialists of South Florida Delray Beach Florida 33484
East Coast Institute for Research, LLC Jacksonville Florida 32256
Central Florida Eye Associates Lakeland Florida 33805
The Eye Institute of West Florida Largo Florida 33770
Lee Shettle Eye Largo Florida 33773
North Georgia Eye Associates Gainesville Georgia 30501
Coastal Research Associates Roswell Georgia 30076
Kannarr Eye Care LLC Pittsburg Kansas 66762
NorthEast Eye Research Associates, LLC Westborough Massachusetts 01581
Coldwater Vision Research Coldwater Mississippi 38618
Las Vegas Eye Institute Henderson Nevada 89052
Rochester Ophthalmological Group Rochester New York 14618
Albemarle Eye Center Elizabeth City North Carolina 27909
Oculus Research, Inc. Garner North Carolina 27529
CORE, Inc. Shelby North Carolina 28150
Midwest Eye Center Cincinnati Ohio 45236
University Hospitals Cleveland Medical Center Cleveland Ohio 44106
Scott & Christie and Associates, PC Cranberry Township Pennsylvania 16066
Southern College of Optometry Memphis Tennessee 38104
Total Eye Care, PA Memphis Tennessee 38119
The Eye Institute of Utah Salt Lake City Utah 84107
Piedmont Eye Center Lynchburg Virginia 24502

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07082816, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 20, 2026 · Synced May 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07082816 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →